Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2011
12/14/2011EP2393826A2 Novel saponin compounds, methods of preparation thereof, use thereof and pharmaceutical compositions
12/14/2011EP2393825A2 Oligomeric compounds and methods
12/14/2011EP2393818A2 Triptolide c-ring derivatives as anticancer agents and immune modulators
12/14/2011EP2393816A2 Inhibitors of bruton's tyrosine kinase
12/14/2011EP2393815A2 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
12/14/2011EP2393814A1 Pyrrolopyrimidinyl axl kinase inhibitors
12/14/2011EP2393812A1 Substituted spiro-amides as b1r modulators
12/14/2011EP2393810A1 Phthalazine-containing antidiabetic compounds
12/14/2011EP2393809A2 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
12/14/2011EP2393808A1 Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
12/14/2011EP2393807A1 Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1
12/14/2011EP2393806A1 Inhibitors of jun n-terminal kinase
12/14/2011EP2393804A1 Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
12/14/2011EP2393803A1 Substituted indole compounds as bradykinin receptor 1 modulators
12/14/2011EP2393802A1 Dihydroquinolinone derivatives
12/14/2011EP2393801A2 Indole derivatives as anticancer agents
12/14/2011EP2393794A1 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
12/14/2011EP2393793A1 Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
12/14/2011EP2393792A1 Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
12/14/2011EP2393791A1 Derivatives of 6-(6-o-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
12/14/2011EP2393790A1 Derivatives of 6-(6-o-cycloalkyl or 6-nh-cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
12/14/2011EP2393789A1 Isoxazole-3-carboxamide derivatives
12/14/2011EP2393788A1 Isoxazole-5-carboxamide derivatives
12/14/2011EP2393787A2 Cadherin-11 inhibitors and methods of use thereof
12/14/2011EP2393786A2 Novel polymorphs of lopinavir
12/14/2011EP2393784A1 Novel method for the synthesis of ivabradine and the pharmaceutically acceptable acid addition salts thereof
12/14/2011EP2393782A1 Benzoic acid (1-phenyl-2-pyridin-4-yl) ethyl esters as phosphodiesterase inhibitors
12/14/2011EP2393781A1 Dihydropyridone ureas as p2x7 modulators
12/14/2011EP2393780A1 Heterocyclic derivatives as m-glu5 antagonists
12/14/2011EP2393778A1 Optically active 3-[(phenylpiperazin-1-yl)alkyl]-3- alkyl-oxindole derivatives having cns activity
12/14/2011EP2393552A1 A novel cyanopyrimidine derivative
12/14/2011EP2393516A1 Stable, taste and odor masked pharmaceutical compositions comprising acetylcystein and vitamin c
12/14/2011EP2393506A1 Methods and compositions for treating neuropathies
12/14/2011EP2393498A1 Cancer diagnosis and treatment
12/14/2011EP2393496A1 Improved vaccines for human papilloma virus and methods for using the same
12/14/2011EP2393495A1 Carjbamoylphosphonates as inhibitors and uses thereof
12/14/2011EP2393494A1 Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
12/14/2011EP2393493A1 Compounds
12/14/2011EP2393492A1 New pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
12/14/2011EP2393491A2 Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
12/14/2011EP2393490A1 Taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
12/14/2011EP2393489A2 Moisture-activated granulation process
12/14/2011EP2393488A1 Therapeutic compositions comprising monoterpenes
12/14/2011EP2393482A2 Process for the preparation of a pharmaceutical composition comprising ezetimibe
12/14/2011EP2393480A1 Methods of reducing the proliferation and viability of microbial agents
12/14/2011EP2393478A2 Taste and odor masked pharmaceutical compositions with high bioavailability
12/14/2011EP2393477A1 Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma
12/14/2011EP2393474A2 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
12/14/2011EP2393473A1 Buccal application system comprising 17a-estradiol
12/14/2011EP2393472A1 Amphiphile prodrugs
12/14/2011EP2393364A1 Treatment of lung cancer with a parp inhibitor in combination with a growth factor inhibitor
12/14/2011EP2393361A1 Pharmaceutical grade phthalazinediones, process for their preparation and pharmaceutical compositions containing them
12/14/2011EP2393360A1 Pyridazinone compounds
12/14/2011EP2393359A1 Linked dibenzimidazole derivatives
12/14/2011EP2393358A1 Traitement d'événements cardiaques majeurs indésirables et du syndrome coronaire aigu à l'aide de traitements thérapeutiques utilisant un inhibiteur de la phospholipase sécrétée a2 (spla2) ou de combinaisons thérapeutiques avec un inhibiteur de spla2
12/14/2011EP2393357A1 Pyrrolidine triple reuptake inhibitors
12/14/2011EP2393355A1 Method of treating dry eye disease with azithromycin
12/14/2011EP2393353A1 Compositions and methods for organ preservation
12/14/2011EP2300484B1 Novel class of spiro piperidines for the treatment of neurodegenerative diseases
12/14/2011EP2257526B1 Spiro(5.5)undecane derivatives
12/14/2011EP2240487B1 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments
12/14/2011EP2217219B1 A sublingual effervescent tablet of progesterone associated with cyclodextrin
12/14/2011EP2217210B1 Sustained release tablets with hydromorphone
12/14/2011EP2215093B1 Novel piperazino-dihydrothienopyrimidine derivatives
12/14/2011EP2209501B1 Zibotentan composition containing mannitol and microcrystalline cellulose
12/14/2011EP2197450B1 7-keto dhea for psychiatric use
12/14/2011EP2178840B1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
12/14/2011EP2167499B1 Substituted oxazolidinones and use thereof
12/14/2011EP2089367B1 Pyrazoline compounds as mineralocorticoid receptor antagonists
12/14/2011EP2079725B1 Piperidyl-propane-thiol ccr3 modulators
12/14/2011EP2069364B1 Novel 5, 7-disubstituted [1, 3]thiazolo [4, 5-d]pyrimidin-2 (3h)-one derivatives and their use in therapy
12/14/2011EP2069310B1 Sulfonylpyrazoline-1-carboxamidine derivatives as 5-ht6 antagonists
12/14/2011EP2021324B1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/14/2011EP1968977B1 Aryl-isoxazol-4-yl-imidazo[1,5-a]pyridine derivatives
12/14/2011EP1948615B1 Pyrazole derivatives useful for the treatment of gynaecological diseases
12/14/2011EP1944028B1 Solid oral forms of ebastine
12/14/2011EP1937366B1 Synergistic mixtures of bisabolol and ginger extract
12/14/2011EP1934206B1 Phenyl- and pyridyl-i, 2 , 4 -oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals
12/14/2011EP1928851B1 Vitamin d derivatives active on the vitamin d nuclear receptor, preparation and uses thereof
12/14/2011EP1917262B1 Piperidine and piperazine derivatives as p2x3 antagonists
12/14/2011EP1893582B1 Compounds, their pharmaceutical compositions and their use in treating metabolic disorders
12/14/2011EP1861399B1 Cgrp receptor antagonists
12/14/2011EP1828160B1 Sulfonyl amino cyclic derivatives and use thereof as mmp inhibitors
12/14/2011EP1794133B1 Aryl spirolactam cgrp receptor antagonists
12/14/2011EP1794123B1 3-spiro-indolin-2-one derivatives as vasopressin receptor ligand
12/14/2011EP1781593B1 Cationic lipids and methods of use
12/14/2011EP1742638B1 Composition comprising a diuretic and cardiac glycoside for the treatment of dna viral infections of the eye
12/14/2011EP1737832B1 4-anilinoquinazoline derivatives with adenosine-kinase inhibitory properties
12/14/2011EP1712547B1 Bicycloester derivative
12/14/2011EP1698635B1 Benzimidazole derivatives and medical uses thereof
12/14/2011EP1641492B1 Controlled platelet activation to monitor therapy of adp antagonists
12/14/2011EP1635787B1 Bioerodible sustained release drug delivery systems
12/14/2011EP1616866B1 M-stage kinesin inhibitor
12/14/2011EP1587479B1 Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases
12/14/2011EP1532122B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/14/2011EP1531851B1 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
12/14/2011EP1526894B1 Use of a ppar-alpha agonist to treat weight gain associated with a ppar-gamma agonist treatment
12/14/2011EP1513529B1 Triple monoamine reuptake inhibitors for the treatment of chronic pain
12/14/2011EP1446106B1 Optimal polymer mixtures for gastric retentive tablets
12/14/2011EP1436277B1 A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate
1 ... 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 ... 7860